Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study
Zamarin, Dmitriy, Burger, Robert A, Sill, Michael W, Powell, Jr, Daniel J, Lankes, Heather A, Feldman, Michael D, Zivanovic, Oliver, Gunderson, Camille, Ko, Emily, Mathews, Cara, Sharma, Sudarshan, Hagemann, Andrea R, Khleif, Samir, Aghajanian, Carol
Published in Journal of clinical oncology (01.06.2020)
Published in Journal of clinical oncology (01.06.2020)
Get full text
Journal Article
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Tewari, Krishnansu S, Burger, Robert A, Enserro, Danielle, Norquist, Barbara M, Swisher, Elizabeth M, Brady, Mark F, Bookman, Michael A, Fleming, Gini F, Huang, Helen, Homesley, Howard D, Fowler, Jeffrey M, Greer, Benjamin E, Boente, Matthew, Liang, Sharon X, Ye, Chenglin, Bais, Carlos, Randall, Leslie M, Chan, John K, Ferriss, J Stuart, Coleman, Robert L, Aghajanian, Carol, Herzog, Thomas J, DiSaia, Philip J, Copeland, Larry J, Mannel, Robert S, Birrer, Michael J, Monk, Bradley J
Published in Journal of clinical oncology (10.09.2019)
Published in Journal of clinical oncology (10.09.2019)
Get full text
Journal Article
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Burger, Robert A, Brady, Mark F, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Huang, Helen, Mannel, Robert S, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew, Birrer, Michael J, Liang, Sharon X
Published in The New England journal of medicine (29.12.2011)
Published in The New England journal of medicine (29.12.2011)
Get full text
Journal Article
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study
Norquist, Barbara M, Brady, Mark F, Harrell, Maria I, Walsh, Tom, Lee, Ming K, Gulsuner, Suleyman, Bernards, Sarah S, Casadei, Silvia, Burger, Robert A, Tewari, Krishnansu S, Backes, Floor, Mannel, Robert S, Glaser, Gretchen, Bailey, Cheryl, Rubin, Stephen, Soper, John, Lankes, Heather A, Ramirez, Nilsa C, King, Mary Claire, Birrer, Michael J, Swisher, Elizabeth M
Published in Clinical cancer research (15.02.2018)
Published in Clinical cancer research (15.02.2018)
Get full text
Journal Article
American Society of Clinical Oncology position statement on obesity and cancer
Ligibel, Jennifer A, Alfano, Catherine M, Courneya, Kerry S, Demark-Wahnefried, Wendy, Burger, Robert A, Chlebowski, Rowan T, Fabian, Carol J, Gucalp, Ayca, Hershman, Dawn L, Hudson, Melissa M, Jones, Lee W, Kakarala, Madhuri, Ness, Kirsten K, Merrill, Janette K, Wollins, Dana S, Hudis, Clifford A
Published in Journal of clinical oncology (01.11.2014)
Published in Journal of clinical oncology (01.11.2014)
Get full text
Journal Article
Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
BURGER, Robert A, SILL, Michael W, MONK, Bradley J, GREER, Benjamin E, SOROSKY, Joel I
Published in Journal of clinical oncology (20.11.2007)
Published in Journal of clinical oncology (20.11.2007)
Get full text
Journal Article
Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer
CANNISTRA, Stephen A, MATULONIS, Ursula A, MCGUIRE, William, PENSON, Richard T, HAMBLETON, Julie, DUPONT, Jakob, MACKEY, Howard, DOUGLAS, Jeffrey, BURGER, Robert A, ARMSTRONG, Deborah, WENHAM, Robert
Published in Journal of clinical oncology (20.11.2007)
Published in Journal of clinical oncology (20.11.2007)
Get full text
Journal Article
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
Wright, Alexi A, Cronin, Angel, Milne, Dana E, Bookman, Michael A, Burger, Robert A, Cohn, David E, Cristea, Mihaela C, Griggs, Jennifer J, Keating, Nancy L, Levenback, Charles F, Mantia-Smaldone, Gina, Matulonis, Ursula A, Meyer, Larissa A, Niland, Joyce C, Weeks, Jane C, O'Malley, David M
Published in Journal of clinical oncology (10.09.2015)
Published in Journal of clinical oncology (10.09.2015)
Get full text
Journal Article
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer
Meyer, Larissa A, Cronin, Angel M, Sun, Charlotte C, Bixel, Kristin, Bookman, Michael A, Cristea, Mihaela C, Griggs, Jennifer J, Levenback, Charles F, Burger, Robert A, Mantia-Smaldone, Gina, Matulonis, Ursula A, Niland, Joyce C, O'Malley, David M, Wright, Alexi A
Published in Journal of clinical oncology (10.11.2016)
Published in Journal of clinical oncology (10.11.2016)
Get full text
Journal Article
Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
MONK, Bradley J, SILL, Michael W, BURGER, Robert A, GRAY, Heidi J, BUEKERS, Thomas E, ROMAN, Lynda D
Published in Journal of clinical oncology (01.03.2009)
Published in Journal of clinical oncology (01.03.2009)
Get full text
Journal Article
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
BOOKMAN, Michael A, BRADY, Mark F, MUTCH, David G, BURGER, Robert A, SWART, Ann Marie, TRIMBLE, Edward L, ACCARIO-WINSLOW, Chrisann, ROTH, Lawrence M, MCGUIRE, William P, HARPER, Peter G, ALBERTS, David S, FRIEDLANDER, Michael, COLOMBO, Nicoletta, FOWLER, Jeffrey M, ARGENTA, Peter A, DE GEEST, Koen
Published in Journal of clinical oncology (20.03.2009)
Published in Journal of clinical oncology (20.03.2009)
Get full text
Journal Article
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Armstrong, Deborah K, Bundy, Brian, Wenzel, Lari, Huang, Helen Q, Baergen, Rebecca, Lele, Shashikant, Copeland, Larry J, Walker, Joan L, Burger, Robert A
Published in The New England journal of medicine (05.01.2006)
Published in The New England journal of medicine (05.01.2006)
Get full text
Journal Article
PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
NAUMANN, R. Wendel, COLEMAN, Robert L, GERSH, Robert H, TENERIELLO, Michael G, HARB, Wael A, KONSTANTINOPOULOS, Panagiotis A, PENSON, Richard T, SYMANOWSKI, James T, LOVEJOY, Chandra D, LEAMON, Christopher P, MORGENSTERN, David E, MESSMANN, Richard A, BURGER, Robert A, SAUSVILLE, Edward A, KUTARSKA, Elzbieta, GHAMANDE, Sharad A, GABRAIL, Nashat Y, DEPASQUALE, Stephen E, NOWARA, Elzbieta, GILBERT, Lucy
Published in Journal of clinical oncology (10.12.2013)
Published in Journal of clinical oncology (10.12.2013)
Get full text
Journal Article
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study
Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A
Published in Gynecologic oncology (01.10.2015)
Published in Gynecologic oncology (01.10.2015)
Get full text
Journal Article
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
OZOLS, Robert F, BUNDY, Brian N, GREER, Benjamin E, FOWLER, Jeffrey M, CLARKE-PEARSON, Daniel, BURGER, Robert A, MANNEL, Robert S, DEGEEST, Koen, HARTENBACH, Ellen M, BAERGEN, Rebecca
Published in Journal of clinical oncology (01.09.2003)
Published in Journal of clinical oncology (01.09.2003)
Get full text
Journal Article
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study
Walker, Joan L., Armstrong, Deborah K., Huang, Helen Q., Fowler, Jeffrey, Webster, Kenneth, Burger, Robert A., Clarke-Pearson, Daniel
Published in Gynecologic oncology (2006)
Published in Gynecologic oncology (2006)
Get full text
Journal Article
Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
BURGER, Robert A, BRADY, Mark F, LIM, Peter C, RUBIN, Stephen C, KATSUMATA, Noriyuki, LIANG, Sharon X, BOOKMAN, Michael A, MONK, Bradley J, WALKER, Joan L, HOMESLEY, Howard D, FOWLER, Jeffrey, GREER, Benjamin E, BOENTE, Matthew, FLEMING, Gini F
Published in Journal of clinical oncology (20.04.2014)
Published in Journal of clinical oncology (20.04.2014)
Get full text
Journal Article
Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer
Burger, Robert. A, Brady, Mark F, Rhee, Joon, Sovak, Mika A, Kong, George, Nguyen, Hoa P, Bookman, Michael A
Published in Gynecologic oncology (01.10.2013)
Published in Gynecologic oncology (01.10.2013)
Get full text
Journal Article